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Abstract 
Bone resorption by the osteoclast is dependent on acidification of the bone surface by a vacuolar type H+-ATPase (V-ATPase) present 
in the ruffled membrane of the actively resorbing cell. V-ATPases are a highly conserved family of proton pumps consisting of two 
functional complexes: a cytoplasmic catalytic sector (V,) and a membrane bound proton channel (V,). Bafilomycin A,, a macrolide 
antibiotic, is a highly potent inhibitor of V-ATPases, and inhibits bone resorption in vitro in isolated rat calvariae. In order to investigate 
the binding of bafilomycin to the osteoclast V-ATPase, we used a tritiated bafilomycin which had been prepared by acetylating the 
21-hydroxyl group of bafilomycin A ,. Osteoclast ruffled membrane vesicles were prepared from purified chicken osteoclasts by 
differential centrifugation and proton transport in these vesicles was shown to be inhibited by [“Hlbafilomycin (IC,, = 2 nM). Control 
membrane vesicles or membrane vesicles partially inhibited with [‘Hlbafilomycin were solubilized and separated by centrifugation on 
15-30% glycerol gradients. V-ATPase activity and reconstitutable proton transport activity could be recovered in high density fractions of 
the gradient. However, the peak of [3H]bafilomycin radioactivity (> 70% of total radioactivity in the gradient) was present in a single 
peak at lower density. Antibodies against subunits of V, (70, 56 and 40 kDa) reacted only in fractions containing the peak V-ATPase 
activity whereas an antibody to the 39 kDa subunit of V, reacted both with fractions containing the peak V-ATPase activity but also, and 
more strongly, in fractions containing the peak [‘H]bafilomycin. The fractions in the control gradient corresponding to the peak of 
[ ‘H]bafilomycin were reconstituted into liposomes and shown to mediate passive bafilomycin A, -inhibitable proton conductance. 
SDS-PAGE followed by autoradiography, indicated that the bafilomycin was not covalently bound to the V-ATPase or the proton 
channel. Quantification of V, by [ 3H]bafilomycin binding or by antibody staining suggested an excess of the free proton channel to that 
of the intact holoenzyme. A corresponding amount of free catalytic sector could not be found in any fraction throughout the isolation 
procedure of the V-ATPase from the initial homogenate. Thus, in conclusion, bafilomycin inhibits the V-ATPase by binding tightly but 
non-covalently to the proton channel region of the V-ATPase which appears to be present in excess over the intact holoenzyme in the 
osteoclast. The possible role of an excess of the proton channel subcomplex in the osteoclast is discussed. 
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1. Introduction 
Vacuolar H+-ATPases (V-ATPases) are heteromulti- 
merit proton pumps responsible for the acidification of a 
variety of intracellular organelles in the eukaryotic cell, 
including clathrin-coated vesicles, lysosomes and chromaf- 
Abbreviations: C ,? E,, polyoxyethylene 9.lauryl ether; DTT, dithio- 
threitol; Hepes, N-@hydroxyethyl)-N/-(2-ethanesulfonic acid); Tris, 
tris(hydroxymethyl)aminomethane; Mes, 2-(N-morpholine)ethanesulfonic 
acid; SDS. sodium dodecylsulfate; PAGE, polyacrylamide gelelec- 
trophoresis; EGTA, (ethylenebis(oxyethylenenitrilo))tetraacetic acid: 
EDTA, (ethylenedinitrilo)tetraacetic acid. 
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fin granules [I]. In some cells, such as the osteoclast and 
the renal intercalated cell, V-ATPases are found at high 
density in the plasma membrane where they are involved 
in acid transport out of the cell [2-51. In the active 
osteoclast, V-ATPase is polarized to a region of the plasma 
membrane, known as the ruffled membrane, which faces 
the bone surface [2,3]. Protons are secreted into the com- 
partment formed between the bone attachment site, the 
ruffled membrane and the bone surface, and this acidity 
combined with the release of proteolytic enzymes leads to 
bone resorption [6]. 
Recently we partially purified the chicken osteoclast 
ruffled membrane V-ATPase and suggested that this acid 
pump contains subunits of apparent molecular mass 116-, 
71-, 57-,40-, 39-, 33- and 17-kDa subunits [4]. This is very 
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similar to the basic subunit structure reported for other 
V-ATPases that have been characterized 111. The exact 
subunit composition is not known for any V-ATPase and 
the number of polypeptides found to be present in prepara- 
tions from different sources show some variation. It is not 
yet clear if these variations represent genuine subunits, 
contaminants or regulatory proteins. However, evidence 
suggests that the V-ATPase subunits are grouped into two 
distinct functional complexes: a catalytic hydrophilic sec- 
tor (Vc) containing the 71-, 57-, 40- and 33-kDa subunits 
and a transmembranous proton channel (V,) containing the 
116-, 39- and 17-kDa subunits [4,7,8]. 
One of the major functional characteristics of the V- 
ATPases is their sensitivity to a group of macrolide antibi- 
otics, the bafilomycins [9]. Bafilomycin A,, specifically 
inhibits V-ATPases at nanomolar concentrations whereas 
at least micromolar concentrations are needed to inhibit 
other types of ATPases. We [4,10] and others [ 1 11, have 
shown that bafilomycin A, inhibits the osteoclast H+- 
ATPase at nanomolar concentrations and also inhibits bone 
resorption in vitro in mouse calvariae. The mechanism of 
action and the binding site(s) of bafilomycin to the V- 
ATPase are poorly understood [ 12,131. Recently, however, 
Crider et al. [8] showed that the isolated transmembranous 
complex is a functional proton conductance which is highly 
sensitive to bafilomycin A,. In order to get more insight 
into the mechanism of action of bafilomycin, we have 
investigated the binding of a tritiated bafilomycin to the 
osteoclast H+-ATPase. 
2. Experimental procedures 
2.1. Materials 
Acridine orange was obtained from Kodak; phospha- 
tidylcholine, phosphatidylethanolamine and phosphatidyl- 
serine from Avanti Polar Lipids (Birmingham, AL); cholic 
acid was obtained from Calbiochem. Bafilomycin A ,, 
isolated from Streptomyces sp., was purified by Astra 
Hassle AB, Miilndal, Sweden. The tritiated bafilomycin 
(108 kBq/nmol, 99% radiochemical purity) was prepared 
by Astra Hassle AB by acetylating the 21-hydroxyl group 
of bafilomycin. The clathrin-coated vesicle H+-ATPase 
[14], the antibodies to the 70-, 40-, and 39-kDa subunits 
[15,16]), were generous gifts from Prof. Dennis Stone, 
Department of Internal Medicine, University of Texas 
Southwestern Medical Center, Dallas, Texas. The antibody 
to the 56 Da subunit (against the B2 isoform) was prepared 
as described [17]. All other chemicals were obtained from 
Sigma. 
2.2. Isolation of osteoclast vacuolar H +-ATPuse 
Osteoclasts were isolated from egg laying hens after 
14-days on a calcium-deprived diet as previously described 
[4] with the exception that only one serum gradient was 
used. A final osteoclast purity of approx. 1:15 
(osteoclast/contaminating cells) was obtained. Due to the 
large size of the osteoclast (50- 100 pm) compared to the 
smaller contaminating cells it is estimated that greater than 
75% of the plasma membranes were derived from osteo- 
clasts in this preparation. 
Osteoclast plasma membrane vesicles containing the 
ruffled membrane were prepared as described by Blair et 
al. [18]. Briefly, osteoclasts were resuspended in isolation 
buffer (5 mM Tris-HCl, pH 7.0, 1 mM NaHCO,, 250 mM 
sucrose, 1 mM EGTA and 1 mM DTT) and then disrupted 
by nitrogen cavitation in a cell disruption bomb (40 atm 
for 25 min). The homogenate (H) was centrifuged at 
1000 X g for 5 min to obtain a supematant (S 1) and a 
pellet (Pl). S 1 was centrifuged at 6000 X g for 15 min 
giving a supematant (S2) and a pellet (P2). S2 was cen- 
trifuged for 40000 X for 45 min generating the final 
supematant (S3) and pellet (P3). P3, containing the mem- 
brane vesicles, was resuspended in isolation buffer and 
frozen at -70°C. The osteoclast membrane vesicle prepa- 
ration used in the present study was previously charac- 
terized by cell surface labelling which indicated that at 
least 25% of the total membranes and 50% of the vesicles 
in the preparation were derived from the osteoclast ruffled 
membrane [ 181. In the experiment shown in Fig. 1, mem- 
brane vesicles were prepared directly from medullary bone 
of egg laying hens without first purifying the osteoclasts 
[191. 
The vacuolar H+-ATPase present in the osteoclast 
membrane vesicles was further purified as described [4], 
with some modifications. Briefly, membrane vesicles were 
diluted to = 3 mg protein/ml in isolation buffer (5 mM 
Tris-HCl, pH 7.0, 250 mM sucrose, 1 mM EGTA and 10 
mM DTT). The membranes were then solubilized by incu- 
bation in the presence of 1.5% C ,?E9 for 1 h 15 min at 
5°C followed by centrifugation at 90000 X g for 45 min at 
4°C. The supernatant was removed and layered onto a 3.5 
ml 15-30% (v/v) glycerol gradient prepared in buffer A 
(20 mM Tris-Mes, pH 7.0, 0.05% C ,2E9, 10 mM DTT and 
1 mM EGTA). The gradients were centrifuged at 485000 
X g for 5 h 30 min, and fractions were collected from the 
bottom of the gradient. In some experiments, fractions 
containing bafilomycin A ,-sensitive ATPase activity were 
pooled, concentrated in Centrikon 10 concentrators and 
centrifuged on a second 15-30% glycerol density gradient. 
Where indicated, membrane vesicles or the partially puri- 
fied ATPase were preincubated with [‘Hlbafilomycin or 
ethanol (control) for 5 min prior to separation as described 
above. Radioactivity in fractions was measured by liquid 
scintillation spectroscopy in a Wallac Microbeta scintilla- 
tor counter (Wallac, Finland). For autoradiography, frac- 
tions were separated by SDS-PAGE using 12.5% poly- 
acrylamide gels. After electrophoresis, the gels were incu- 
bated in fixing solution (isopropanol/acetic acid/H,O; 
25: 10:65) for 30 min at room temperature, followed by 30 
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min incubation in amplifier (Amplify, Amersham). The 
gels were then dried under vacuum and then exposed to 
film for up to 5 weeks at - 70°C. 
The osteoclast V-ATPase was dissociated into Vc and 
V, complexes using cold inactivation [19,20]. Medullary 
bone membrane vesicles, prepared as described above, 
were incubated in dissociation solution (400 mM KI, 5 
mM ATP (pH 7.0 with Tris), 5 mM MgSO,, 1 mM DTT, 
0.5 mM EDTA) for 1 h on ice, followed by centrifugation 
at 100000 X g for 1 h at 4°C. The pellet was resuspended 
in isolation buffer (5 mM Tris, pH 7.0, 1 mM EGTA and 
250 mM sucrose) and both the resuspended pellet and the 
supernatant were incubated in the presence of 1.5%C ,* E, 
and 10 mM DTT for 1 h 15 min at 5°C. After centrifuga- 
tion at 90000 X g for 45 min, the supematants were 
loaded onto 15-30% glycerol density gradients and cen- 
trifugation and fractionation was performed as described 
above. 
2.3. SDS-PAGE and Western blot analysis 
SDS-polyacrylamide gel electrophoresis was performed 
according to Laemmli [21] using 12.5% polyacrylamide 
gels. After electrophoresis, the gel was stained with 0.125% 
Coomassie blue R-250 (Sigma). For Western blot analysis, 
protein fractions were separated on 12.5% SDS-polyacryl- 
amide gels and then transferred electrophoretically to a 
nitrocellulose membrane by blotting at 100 V for 1 h using 
a Bio-Rad Trans Blot Cell. After transfer, the membrane 
was washed in rinse buffer (TBS) consisting of 10 mM 
Tris-HCl, pH 7.5, 0.15 M NaCI, 1 mM EDTA and 0.75% 
Tween 20 for 15 min at room temperature followed by 
incubation in TBS containing 5% nonfat dry milk for 2 h 
at room temperature or overnight at 5°C. After a 2 X 15 
min wash in TBS the membrane was incubated for 2 h 
with the primary antibody at appropriate dilution (1:2000 
for the antibodies to the 70 and 40 kDa subunits, I:5000 
for the antibody to the 56 kDa subunit and 1: 10000 for the 
antibody to the 39 kDa subunit). The membrane was then 
washed in TBS and bound antibody detected using 
horseradish peroxidase-linked anti-rabbit immunoglobulin 
(1:4000 dilution) and the ECL-detection kit (Amersham). 
2.4. ATPase acticity measurement 
ATPase activity was measured in a total volume of 250 
~1 by the release of inorganic phosphate from ATP. 
Protein fractions (10 ~1) were preincubated in the presence 
of 6 ~1 0.5 mg/ml phosphatidylserine for 10 min at room 
temperature. 221.5 ~1 reaction mixture (50 mM Tris-Mes, 
pH 7.0, 60 mM KC1 and 5 mM magnesium gluconate) was 
added followed by the addition of 2.5 ~1 bafilomycin A, 
(50 nM, final concentration) or 2.5 ~1 DMSO (control). 
After 5 min pre-incubation at room temperature, the reac- 
tion was initiated by the addition of 10 ,ul 62.5 mM 
Na,ATP (pH 7.0 with Tris base). After 30 min incubation 
at 37°C the reaction was terminated by the addition 25 ~1 
of 50% TCA and released Pi was determined as described 
by Yoda and Hokin [22]. Bafilomycin A,-sensitive ATP- 
ase (V-ATPase) activity was defined as the ATPase activ- 
ity inhibited by 50 nM bafilomycin A,. 
2.5. Reconstitutions and measurement of proton transport 
Liposomes composed of phophatidylcholine, phospha- 
tidylethanolamine, phosphatidylserine and cholesterol at a 
mass ratio of 43:28:2:27 were prepared at a concentration 
of 50 mg/ml by sonication as described by Xie et al. [23] 
with the exception that the lipids were sonicated to clarity 
(= 3 X 10 min). 
Reconstitution of the Hf-ATPase into liposomes was 
performed using the freeze-thaw, cholate dilution method 
[4]. To measure ATP-dependent proton transport, osteo- 
clast membrane vesicles or reconstituted fractions were 
diluted into a 1.6 ml assay buffer containing 5 mM 
Hepes-Tris, pH 7.5, 120 mM KCl, 2.5 mM magnesium 
gluconate and 1 PM acridine orange. Proton transport was 
monitored by measurement of acridine orange fluorescence 
(Ex. = 492, Em. = 528) quenching in a Shimadzu spectro- 
fluorimeter [lo]. Reactions were measured at room temper- 
ature and were initiated by the addition of 1 mM Na,ATP 
(pH 7.0 with Tris base) followed by valinomycin (1 PM, 
final concentration) and terminated after 2 min by the 
addition of 6 mM NH,Cl. Amount of acidification was 
taken to be the difference between the fluorescence before 
and after the addition of NH,Cl and is expressed as 
fluorescence units (F.U.). In the experiments illustrated in 
Fig. 1, medullary bone membrane vesicles (30 yg pro- 
tein/ml) were added to an assay medium containing 120 
mM KCl, MgC12, acridine orange. Bafilomycin A, or the 
[ ‘Hlbafilomycin was added at the indicated concentration, 
with DMSO or ethanol, respectively in the control sam- 
ples, and the samples were preincubated for 10 min at 
room temperature. Reactions were initiated by the addition 
of 1 mM ATP and the decrease in acridine orange ab- 
sorbance at 490 nm was monitored in a microplate reader 
(Molecular Devices, CA, USA). The initial rate of acidifi- 
cation, taken to be the initial decrease in acridine orange 
absorbance, was determined from the slope of the ab- 
sorbance trace after the addition of ATP [ 101. 
To test for the presence of passive proton conductance 
activity, fractions were reconstituted into liposomes using 
the method described by Crider et al. [8]. Briefly, 100 ,ul 
protein fraction and 60 ~1 liposomes were mixed with 30 
~1 reconstitution solution (6% sodium cholate, 30% glyc- 
erol and 740 mM KCl) followed by the addition of 5 ~1 of 
a solution containing 0.6 M DTT and 60 mM CaCl,. The 
mixture was frozen in liquid N?, thawed for 1 h at room 
temperature and then diluted into 7 ml dilution buffer (150 
mM KCl, 20 mM Tricine, pH 7.5, 3 mM MgCl, and 0.5 
mM EDTA). After incubation for 10 min at room tempera- 
ture, the proteoliposomes were pelleted by centrifugation 
J.P. Mattson, D.J. Keeling/Biochimica et Biophyyica Acta 1280 (lYY6i X-106 101 
at 100000 X g for 1 h at 15°C and then resuspended in 50 
~1 dilution buffer. To activate the proton conductance, 10 
~1 of the proteoliposomes were mixed with 4 ~1 0.5 M 
Mes and incubated for 1 h at room temperature. Proton 
conductance activity in the proteoliposomes was measured 
using acridine orange fluorescence as described above with 
the exception that the proteoliposomes were diluted into a 
1.6 ml assay buffer containing 20 mM Tricine, pH 7.5, 150 
mM NaCl, 3 mM MgCl?, 0.5 mM EDTA, 1 PM acridine 
orange and 5 nM bafilomycin A, or DMSO (control). 
Reactions were initiated by the addition of 1 PM valino- 
mycin. 
Baiilomycin A,: R--OH 
[3H]Bafilomycin: R= -OCO$HG 
2.6. Protein determination 
Protein was determined by the Amido-Schwartz method 
1241, with bovine serum albumin as a standard. 
3. Results and discussion 
The inhibitory effect of bafilomycin A, or its tritiated 
21 -acetyl analogue ([ “Hlbafilomycin) on ATP-dependent 
proton transport in medullary bone membrane vesicles was 
similar (Fig. 1). At 30 pg protein/ml, IC,, values were 
1.2 nM and 2.0 nM for bafilomycin A I and [ ‘Hlbafilomy- 
tin, respectively. Thus, acetylation of bafilomycin A, had 
only a marginal effect on its inhibitory potency. Similar to 
previous reports for bafilomycin A, [9,19], the inhibitory 
effect of [“Hlbafilomycin was inversely related to the 
amount of V-ATPase preparation present in the assay 
(result not shown). 
0.1 1 10 100 
Concentration (nM) 
To investigate the binding of the [‘Hlbafilomycin to the 
V-ATPase, osteoclast membrane vesicles (= 2.5 mg pro- 
tein/ml) were either incubated in the presence of ethanol 
(control) or [ 3 Hlbafilomycin. At this protein concentration 
it was found that 280 nM [3H]bafilomycin resulted in 
about 60% inhibition of both proton transport and 
bafilomycin A ,-sensitive ATPase activity (Table 1). After 
incubation, the membranes were then treated with 1.5% 
C ,2E9, centrifuged and proteins in the supematant sepa- 
rated on a 15-30% glycerol density gradient. As illustrated 
in Fig. 2, V-ATPase and reconstitutable ATP-dependent 
H+-transport could be recovered from high density frac- 
Fig. 1. Comparison of the inhibitory effects of bafilomycin A, and 
[‘Hlbafilomycin on proton transport in bone membrane vesicles. (A) The 
structures of bafilomycin A, and its tritiated 21-acetyl analogue 
([ ‘H]bafilomycin). The acetyl group was tritiated ( * ). (B) ATP-depen- 
dent proton transport in bone membrane vesicles was measured as 
described under Section 2 in the presence or absence of the indicated 
concentrations of bafilomycin A, (closed circles) or [3H]bafilomycin 
(open circles). The initial rate of acidification in the control samples was 
set to 100%. Values are the mean + range of two determinations from a 
representative experiment, Error bars smaller than the symbol are not 
shown. 
tions of the gradient. This was true for both the control and 
the [ 3H]bafilomycin pre-treated samples. Consistent with 
the 60% inhibition of the starting material, the gradient on 
which [ 3H]bafilomycin pre-treated proteins had been loaded 
contained 29 f 1% of the bafilomycin A ,-sensitive ATP- 
Table 1 
Solubilization and glycerol gradient separation of osteoclast membrane vesicles in the presence or absence [3H]bafilomycin 
Fraction V-ATPase activity (nmol min- ’ ) 
control [3H]Baf. (5%) 
Acidification (F.U.) 




152k31 64i I8 42+ 15 370 139 38 
56f 17 23k IO 41+22 1400 300 21 
89+ 2 26 f 0.5 29f 1 815 k 43 415 + 72 51 i9 
Bafilomycin A,-sensitive ATPase activity (V-ATPase) and ATP-dependent acidification in fractions obtained during solubilization and separation of 
osteoclast membranes which had been pre-treated with ethanol (control) or [‘Hlbafilomycin as described in the legend to Fig. 2 were measured as detailed 
under Section 2. Values are the mean f SE. of two or three determinations from a representative experiment except for the values of acidification in 
osteoclast membranes and solubilized membranes which are one determination from a representative experiment. Acidification in solubilized fractions 
were measured after reconstitution into liposomes as described in Section 2. 
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Fig. 2. Distribution of bafilomycin A,-sensitive ATPase activity and 
[ ‘Hlbafilomycin radioactivity after separation of solubilized osteoclast 
membrane vesicles on a glycerol gradient. Osteoclast membrane vesicles 
were incubated in the presence or absence (control) of [3H]batilomycin 
and then treated with 1.5% C ,? E,. Solubilized proteins were centrifuged 
on a 1530% glycerol density gradient and fractions were collected from 
the bottom (Fraction 1 = 308 glycerol) to the top (Fraction 14). ATPase 
activity and radioactivity were measured in the fractions as described in 
Section 2. Bafilomycin A ,-sensitive ATPase activity in fractions from the 
control gradient (closed circles) and radioactivity in fractions from the 
[‘Hlbafilomycin gradient (open circles) are displayed. Values are the 
mean f range of two determinations on separate gradients. 
ase seen on the control gradient and 51 * 9% of total 
reconstitutable ATP-dependent proton transport activity 
(Table 1). Thus, the inhibitory effect of the [3H]bafilomy- 
tin had not been lost during solubilization and isolation on 
the glycerol gradient, suggesting either tight binding to the 
ATPase or an irreversible mechanism. SDS-PAGE showed 
the presence of the expected V-ATPase poiypeptides of 
apparent molecular masses 72, 56, 42, 39, 32 and 16 kDa 
in fractions containing the V-ATPase (Fig. 3). A loo-120 
kDa peptide which is reported to be present in a number of 
Table 2 
Distribution of radioactivity in fractions during solubilization and separa- 
tion of [ ‘H]bafilomycin pre-treated osteoclast membrane vesicles 
Osteoclast membranes 
Solubilized membranes 
Gradient, fr I - 14 
Gradient, fr 3-6 
Gradient, fr 8- 1 I 
Total radioactivity 













Radioactivity in fractions obtained after solubilization and separation of 
osteoclast membranes treated with [‘H]bafilomycin as described in the 
legend to Fig. 2 was measured as described under Section 2. Values are 
the mean + range of two determinations from a representative experiment. 
V-ATPase preparations could not be seen in the fractions 
correlating with the peak V-ATPase using Coomassie 
staining. However, we have previously reported that prob- 
lems can occur detecting this subunit in preparations of the 
osteoclast V-ATPase [4] and the loo-120 kDa subunit of 
V-ATPase from other sources is reported to be unstable 
and sensitive to proteinase digestion [25]. There was no 
detectable difference in the polypeptide patterns or inten- 
sity of Coomassie staining between gradient fractions con- 
taining [ “Hlbafilomycin pre-treated proteins and the con- 
trol gradient fractions, indicating that bafilomycin does not 
induce loss of known V-ATPase subunits. 
Despite the fact that [“Hlbafilomycin was recovered 
quantitatively from the glycerol gradient and that 
[ 3 Hlbafilomycin-treated ATPase remained inhibited after 
glycerol gradient separation (Tables 1 and 2) no peak of 
radioactivity was found in fractions containing the intact 
V-ATPase (Fig. 2). Instead, a peak of radioactivity (= 74% 
of the total radioactivity applied, Table 2) was present in 
lower density fractions of the gradient (Fig. 2). This 







1 2 3 4 5 6 7 8 9 10 11 12 13 14 
Fig. 3. SDS-PAGE of fractions from glycerol density gradient separation of solubilized osteoclast membrane vesicles. Fractions (10 ,ul of fractions I-14) 
from the experiment described in the legend to Fig. 2 were separated by SDS-PAGE using 12.5% polyacrylamide gels. The figures to the left indicate the 
apparent molecular weight of the major bands seen in fraction 4. 
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[3H]bafilomycin loaded onto a glycerol density gradient in [’ Hlbafilomycin binding contained a functional proton 
the absence of protein but in the presence of 1.5% C,,E, channel we used the method recently described for recon- 
did not migrate into the gradient (result not shown). As can stitution of the transmembranous sector of the clathrin- 
be seen in Fig. 3, fractions in the glycerol gradient that coated vesicle H+-ATPase [S]. Fractions from the control 
held the peak of [‘Hlbafilomycin radioactivity appeared gradient and the [ “Hlbafilomycin gradient corresponding 
relatively enriched in polypeptides of apparent molecular to the peak of [ ‘H]bafilomycin radioactivity were reconsti- 
masses of 39 kDa and 16 kDa which were also found in tuted into potassium-loaded vesicles, diluted into potas- 
fractions containing the intact H+-ATPase. As we have sium-free medium and the acidification of the vesicles in 
previously suggested [4], these fractions might contain V,, response to a valinomycin-induced membrane potential 
the transmembranous proton channel subcomplex, of the (inside negative) was measured by acridine orange fluores- 
osteoclast proton pump. The distribution of V-ATPase cence quenching. As shown in Fig. 5. the fraction from the 
polypeptides in the gradient was therefore investigated control gradient (fraction 9, Fig. 2) catalyzed 
more closely by Western analysis using antibodies against valinomycin-dependent proton transport that was not seen 
subunits of the V-ATPase. Antibodies against Vc, the in the absence of reconstituted protein, indicating the 
catalytic subcomplex, of the ATPase (72, 56 and 42 kDa) presence of a functional proton channel. Bafilomycin A, (5 
reacted only in fractions containing the peak V-ATPase nM) inhibited the proton transport (Fig. 5). suggesting that 
(Fig. 4A-C). In contrast, an antibody against a subunit of it derives from a vacuolar ATPase and most probably 
V,, the 39 kDa subunit, reacted both with the peak of represents the free V, subcomplex of the osteoclast V- 
V-ATPase activity and more strongly in fractions contain- ATPase. In contrast to the fraction from the control gradi- 
ing the peak of [‘Hlbafilomycin radioactivity (Fig. 4D). To ent, the corresponding fraction from the [‘Hlbafilomycin 
test whether the fractions corresponding to the peak gradient showed only a small valinomycin-induced acidifi- 
CCV 1 2 3 4 5 6 ‘7 8 9 10 11 12 13 14 
Bottom Top 
P 
CCV 1 2 3 4 5 6 7 8 9 10 11 12 13 14 
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CCV 1 2 3 4 5 6 7 8 9 10 11 12 13 14 
Bottom TOP 
CCV 1 2 3 4 5 6 7 8 9 10 11 12 13 14 
Bottom TOP 
Fig. 4. Western blot of fractions from glycerol density gradient separation of solubilized osteoclast membrane vesicles using antibodies against V-ATPase 
subunits. Fractions (I-14) from the experiment described in the legend to Fig. 2 and the clathrin-coated vesicle H+-ATPase (CCV) were separated by 
SDS-PAGE using 12.57~ polyaqlamide gels. Proteins were transferred electrophoretically to nitrocellulose and Western blot analysis was performed as 
described in Section 2 using antibodies against the 70 kDa (A), 56 kDa (B), 40 kDa (Cl and 39 kDa (D) subunits of the V-ATPase. 






Fig 5. Reconstitution of passive proton conductance. Fractions obtained 
from the glycerol gradient separation of solubilized osteoclast membrane 
vesicles as described in the legend to Fig. 2 containing peak [jH]bafi- 
lomycin radioactivity (C) or the corresponding fractions from the control 
gradient (A and B) were reconstituted into liposomes as described in 
Section 2. Proton transport into the liposomes in response to a valino- 
mycin (VAL, I PM) induced membrane potential, inside negative. was 
measured in the absence (A and C) or presence (B) or of bafilomycin A, 
(5 nM). Reactions were terminated by the addition of NH,CI (6 mM) at 
the indicated points. 
cation, indicating that the bound [ 3H]bafilomycin inhibited 
the proton channel (Fig. 5C). In order to test if bafilomycin 
bound covalently to the either the V-ATPase holoenzyme 
or the V, subcomplex, fractions from the [3H]bafilomycin 
gradient containing these complexes were mixed with 
Laemmli sample buffer in the absence or presence of 
P-mercaptoethanol and separated by SDS-PAGE on 12.5% 
polyacrylamide gels and then analyzed by fluorography as 
described in Section 2. Despite several weeks of exposure 
to film, there were no detectable bands of radioactivity 
either in the separated holoenzyme or the proton channel, 
indicating that [’ Hlbafilomycin does not bind covalently to 
peptides of molecular mass greater than 14 kDa. Taken 
together, the results provide strong evidence that 
bafilomycin inhibits the osteoclast H+-ATPase by binding 
tightly but non-covalently to V,, the proton channel sub- 
complex, of the osteoclast V-ATPase. However, the exact 
subunit(s) to which bafilomycin binds remains to be eluci- 
dated. On the basis of competition studies using V-ATPase 
isolated from bovine brain clathrin coated vesicles it has 
been suggested that the 100 kDa subunit (which in some 
preparations is referred to as the 116 kDa subunit) is 
involved in bafilomycin A, binding [26], however direct 
binding to this subunit has yet to be shown. The presence 
or absence of this subunit in our preparations is presently 
unclear. As can be seen in Fig. 3, fractions holding the V, 
subcomplex contained several Coomassie stained bands in 
the loo-120 kDa region. Furthermore, an antibody to the 
116 kDa clathrin-coated vesicle H+-ATPase reacted, albeit 
weakly, with two peptides in this region (data not shown). 
However, this antibody also reacted with a number of 
other peptides on Western blots so a definite conclusion 
about the presence of this peptide could not be drawn. 
Difficulties also exist detecting the presence of the 116 
kDa subunit in the holoenzyme (see above and Ref. [4]). 
Further work is necessary to determine the exact subunit 
composition of the osteoclast V, subcomplex and the 
bafilomycin-binding components. 
Despite the fact that pretreatment with [3H]bafilomycin 
caused inhibition of ATPase activity in the purified V- 
ATPase, no peak of radioactivity was associated with these 
fractions on the glycerol gradient. However, the following 
calculation suggests that the amount of V-ATPase may 
have been insufficient to give a detectable peak of radioac- 
tivity. The peak bafilomycin A ,-sensitive ATPase activity 
in the control glycerol gradient was 126 + 8 nmol min- ’ 
ml-’ and the corresponding fraction in the [3H]bafilomy- 
tin gradient was inhibited to 50% (fraction 5, Fig. 2). 
Highly purified V-ATPase from clathrin-coated vesicles 
has been reported to have a specific activity of 16 Fmol 
min-’ mg- ’ and a molecular weight of 530 kDa [14]. On 
the assumption that 1 mol of bafilomycin binds per V- 
ATPase and that the counting efficiency for tritium was 
50%, the known specific activity of the [“Hlbafilomycin 
can be used to calculate that 601 cpm/25 ~1 should have 
been present in this fraction. This amount of radioactivity 
is within a factor of two of the experimentally observed 
background radioactivity in this fraction (327 cpm/25 1.~11. 
Allowing for the uncertainty of the assumptions used in 
the calculations, most notably the specific activity of pure 
V-ATPase, the amount of V-ATPase present may have 
been sufficiently low that the failure to detect bound 
[ ‘H]bafilomycin was not unreasonable. 
On the assumption that [3H]bafilomycin acts as a probe 
for the amount of V, (or holoenzyme) in each fraction 
then the data in Table 2 suggest that V, is present in at 
least IO-fold molar excess over the holoenzyme. In order 
to quantify this difference independently, fractions contain- 
ing the bafilomycin-sensitive ATPase activity and the peak 
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[ 3 H]bafilomycin, respectively, were pooled, blotted at se- 
rial dilutions to nitrocellulose and probed with the 39 kDa 
antibody. Densitometry revealed approx. 3-fold excess of 
the 39 kDa peptide in the pooled fractions containing the 
peak radioactivity over the holoenzyme (results not shown). 
Thus, the results indicate an excess of proton channel in 
the gradient of at least 3-fold and perhaps greater than 
1 O-fold. 
The presence of free V, in the gradient might be due to 
the dissociation of the corresponding holoenzyme on the 
glycerol gradient. However, as shown in Fig. 4A-D, pep- 
tides comprising Vc (72, 56 and 42 kDa) were not found in 
fractions other than those containing the holoenzyme. To 
rule out the possibility that free Vc might co-migrate with 
the holoenzyme in the glycerol gradient, we dissociated the 
holoenzyme using cold inactivation of membrane vesicles 
[ 191, as described in Section 2. After removal of the 
membranes by centrifugation, the supematant, containing 
Vc, was treated with C,,E, and run on a 15-30% glycerol 
gradient under the same conditions as in the experiment 
described in the legend to Fig. 2. Western analysis using 
antibodies against subunits of the Vc subcomplex (70 and 
56 kDa) kDa indicated the presence of this peptide in low 
density fractions (fractions lo- 121, indicating that free Vc, 
if present, should have been detectable on the original 
gradient. 
In order to investigate further the stability of the proton 
pump on the gradient, fractions obtained from one glycerol 
gradient containing bafilomycin A ,-sensitive ATPase ac- 
tivity (holoenzyme) were pooled, diluted to decrease the 
glycerol concentration, concentrated in Centrikon- IO con- 
centrators and then incubated in the presence or absence of 
a concentration of [’ Hlbafilomycin giving 100% inhibition 
of reconstitutable proton transport. The control or the 
[ ‘H]bafilomycin-inhibited V-ATPase was then separated 
on a second 15530% glycerol gradient. As shown in Fig. 
6, V-ATPase activity could be recovered in high density 
fractions of the control gradient. After reconstitution into 
liposomes these fractions catalyzed ATP-dependent H+- 
transport (result not shown). Two approximately equal 
peaks of radioactivity could be found in the gradient, one 
at high density corresponding to the fractions containing 
the H+-ATPase and one at lower density fractions corre- 
sponding to the proton channel (Fig. 6). Thus, although 
there was evidence for some dissociation of the V-ATPase 
on the gradient, this was insufficient to explain the large 
excess of the V, subcomplex seen after glycerol gradient 
centrifugation of solubilized membrane vesicles in the 
experiment shown in Fig. 2. 
Another possibly explanation for the excess of the 
proton channel could have been that the Vc subcomplex 
dissociated from the holoenzyme during the preparation of 
the osteoclast membrane vesicles. The presence of free Vc 
in other sub-cellular fractions was investigated by Western 
analysis using the antibody against the 56 kDa subunit 
(Fig. 7). The final supematant (S3) in the preparation 
1 2 3 4 5 6 7 8 Y 10 11 12 
Fraction 
Fig. 6. Glycerol density gradient separation of partially purified osteoclast 
V-ATPase. Osteoclast membrane vesicles were solubilized and separated 
by glycerol gradient centrifugation as described in the legend to Fig. 2. 
Fractions containing peak bafilomycin A, -sensitive ATPase activity were 
pooled, diluted in glycerol free buffer, concentrated in Centrikon-10 
concentrators and incubated in the presence or absence of [‘Hlbafilomy- 
tin followed by centrifugation on 15-30% glycerol gradients. Fractions 
were collected from the bottom (fraction I = 30% glycerol) to the top 
(fraction 12) and balilomycin A, -sensitive ATPase activity in the control 
gradient (tilled circles) and radioactivity (closed circles) in fractions from 
the gradient containing [‘H]bafilomycin pre-treated proteins were mea- 
sured as described under Section 2. The ATPase activity is the mean+ 
range of two determinations. 
where one might expect to find the free hydrophilic Vc 
subcomplex if it had been dissociated, did not show any 
cross-reaction with the 56 kDa antibody. Neither was there 
evidence for any proteolytic fragments of this subunit. The 
second pellet (P2) contained the 56 kDa peptide but this 
fraction also contained ATP-dependent proton transport 
activity, indicating that the holoenzyme was present in this 
fraction (result not shown). 
H PI Sl P2 S2 P3 S3 P3s Ps Ss GPCCV 
-58kDa 
Fig. 7. Western blot analysis using a 56 kDa antibody of subcellular 
fractions obtained by differential centrifugation of disrupted osteoclasts. 
Fractions (7 pg protein) obtained during the preparation and solubiliza- 
tion of osteoclast membrane vesicles as detailed under Section 2 were 
separated by SDS-PAGE using 12.5% polyacrylamide gels. Proteins were 
transferred to nitrocellulose and probed with a 56 kDa subunit antibody. 
H, osteoclast homogenate; Pl, 1000 X g pellet; Sl, 1000 X R supematant; 
P2, 6000X g pellet; S2, 6000X g supernatant; P3, 40000 X g pellet; S3, 
40000X 8 supematant; P3s, P3 used for solubilization; Ps, 90000X g 
pellet after solubilization; Ss, 90000X g supematant after solubilization; 
GP, small pellet after glycerol density gradient separation of Ss; CCV. 
partially purified clathrin-coated vesicle H+-ATPase (0.2 kg protein). 
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Taken together, the results in this report suggest that the 
osteoclasts used for the Hf-ATPase preparation contained 
an excess of the transmembranous proton channel subcom- 
plex, V,. An excess of V, over the holoenzyme has been 
found after solubilization and glycerol gradient separation 
of V-ATPase containing organelles from other sources 
[8,27,28], but if this was due to an excess of the proton 
channel in the original tissue or to dissociation of the 
holoenzyme during isolation was not investigated. The 
physiological relevance of the presence of free V, in the 
osteoclast is not clear. However, the assembly and disas- 
sembly of the holoenzyme might play a regulatory role. In 
vitro, V-ATPases can be inactivated by treatment with 
chaotropic agents which induce dissociation of the holoen- 
zyme [ 19,201. The dissociated free Vc is unable to hydro- 
lyze ATP and the free membrane bound V, does not 
conduct protons, if not activated as in the present study 
[20,27]. Re-association of the subcomplexes restores 
ATP-driven proton transport [20]. It was recently sug- 
gested that dissociation of the catalytic complex of the 
V-ATPase of Munduca sextu larval midgut might play a 
role in the regulation of acid transport activity during 
moulting [29]. The source of the osteoclasts in the present 
study was egg-laying hens. In the 24 h egg-laying cycle of 
the hen, the osteoclasts remain attached to the medullary 
bone during the complete cycle but their activity is regu- 
lated by a cyclic appearance and disappearance of the 
ruffled membrane [30]. It is possible that during inactiva- 
tion of the osteoclasts in the egg-laying cycle. the Vc 
subcomplex is dissociated from the holoenzyme and subse- 
quently broken down whereas the V, subcomplex remains 
in membrane structures in the cell. 
An alternative possibility is that the proton channel 
might play a distinct role in the osteoclast separate from its 
function in the proton pump. There is evidence that V- 
ATPase subunits have other functions in the cell [31]. 
Ductin, a component of gap junctions, has been reported to 
be the same protein as the 16 kDa proteolipid of the 
V-ATPase proton channel [32]. Further studies on the 
relative distributions of the sub-complexes of the V-ATPase 
within the osteoclast as a function of the resorption cycle 
are needed to extend our understanding of the role and 
regulation of the acid pump in the process of bone resorp- 
tion. 
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